SPAC CM Life Sciences (NASDAQ: CMLF) is gaining 16% after Cathie Wood's ARK Investment fund ARKG (ARK Genomic Revolution ETF) disclosed it initiated a new 1,546,926 share stake.
CM Life Sciences is a SPAC that announced this week that it is merging with Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company. CM Life is sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP.
Wood has had a hot hand with picks in Tesla and others, so here latest moves are tracked carefully.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.